Scott Tykodi, M.D., Ph.D.

Scott Tykodi M.D., Ph.D.
faculty member

Scott Tykodi, M.D., Ph.D.

Associate Member
Clinical Research Division, Fred Hutch

Dr. Scott Tykodi specializes in translating immunotherapy advances from the laboratory into the clinic. He has led numerous clinical trials evaluating novel, immune-based therapeutics for patients with kidney cancer or other solid tumors. Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult cells.

For more information, contact:
Samantha Kiriluk
206-606-7341
smlim@seattlecca.org

Other Appointments & Affiliations

Associate Professor, Division of Medical Oncology
University of Washington School of Medicine

Education

Washington University School of Medicine, 1997

Residency: Barnes Hospital Internal Medicine, 1997-2000

Fellowship: University of Washington Medical Oncology, 2000-2003